Comparison of various treatment modalities for acute tinnitus

Laryngoscope

Volumn 121, Issue 12, 2011, Pages 2619-2625

  Shim, Hyun Joon ^a   Jun Song, Seong ^a   Choi, A Young ^a   Hyung Lee, Rae ^a   Won Yoon, Sang ^a  

^a Eulji General Hospital   (South Korea)

Author keywords

alprazolam; dexamethasone; injection; prostaglandin E 1; Tinnitus

Indexed keywords

ALPRAZOLAM; DEXAMETHASONE; LIPOPROSTAGLANDIN E1;

ACUTE DISEASE; ADULT; ARTICLE; AUDITORY THRESHOLD; AWARENESS; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INJECTION; LOUDNESS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; STEROID THERAPY; TINNITUS; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; ALPRAZOLAM; ALPROSTADIL; ANALYSIS OF VARIANCE; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TINNITUS; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 82155191413     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22350     Document Type: Article

References (29)

1. Kiang NY, Moxon EC, Levine RA,. Auditory-nerve activity in cats with normal and abnormal cochleas. In: Sensorineural hearing loss. Ciba Found Symp 1970: 241-273.
2. Hazell JW, Jastreboff PJ,. Tinnitus. I. Auditory mechanisms: a model for tinnitus and hearing impairment. J Otolaryngol 1990; 19: 1-5. (Pubitemid 20101834)
3. Shim HJ, Kim SK, Park CH, et al. Hearing abilities at ultra-high frequency in patients with tinnitus. Clin Exp Otorhinolaryngol 2009; 2: 169-174.
4. Eggermont JJ, Sininger Y,. Correlated neural activity and tinnitus. In:, Vernon JA, Moller AR, eds. Mechanisms of Tinnitus. Needham Heights, MA: Allyn & Bacon; 1995: 21-34.
5. Ochi K, Ohashi T, Kenmochi M,. Hearing impairment and tinnitus pitch in patients with unilateral tinnitus: comparison of sudden hearing loss and chronic tinnitus. Laryngoscope 2003; 113: 427-431. (Pubitemid 36292865)
6. Weiss AD, Weiss ER,. Acoustic trauma: tinnitus and vertigo. J Laryngol Otol 1984; Suppl 9: 82-83. (Pubitemid 15165013)
7. Eggermont JJ,. Central tinnitus. Auris Nasus Larynx 2003; 30 (Suppl): S7-S12. (Pubitemid 36132330)
8. Kaltenbach JA, Zhang J, Finlayson P,. Tinnitus as a plastic phenomenon and its possible neural underpinnings in the dorsal cochlear nucleus. Hear Res 2005; 206: 200-226. (Pubitemid 41080067)
9. Araujo MF, Oliveira CA, Bahmad FM Jr,. Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: does it work? Arch Otolaryngol Head Neck Surg 2005; 131: 113-117. (Pubitemid 40204766)
10. She W, Dai Y, Du X, Chen F, Ding X, Cui X,. Treatment of subjective tinnitus: a comparative clinical study of intratympanic steroid injection vs. oral carbamazepine. Med Sci Monit 2009; 15: P135-P139.
11. Topak M, Sahin-Yilmaz A, Ozdoganoglu T, Yilmaz HB, Ozbay M, Kulekci M,. Intratympanic methylprednisolone injections for subjective tinnitus. J Laryngol Otol 2009; 123: 1221-1225.
12. Haefley W,. Benzodiazepine receptor and ligands: structural and functional difference. In: Hindmarch I, Beaumont G, Brandon S, Leonard BE, eds. Benzodiazepines: Current Concepts. New York, NY: John Wiley & Sons, Inc; 1990: 1-18.
13. Johnson RM, Brummett R, Schleuning A,. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 1993; 119: 842-845. (Pubitemid 23232291)
14. Karetova D, Bultas J, Vondracek V, Aschermann M,. Alprostadil: modes of actions in peripheral arterial occlusive disease. Am J Ther 1997; 4: 359-363. (Pubitemid 27507998)
15. Newman CW, Jacobson GP, Spitzer JB,. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 1996; 122: 143-148. (Pubitemid 26056771)
16. Piccirillo JF, Finnell J, Vlahiotis A, Chole RA, Spitznagel E Jr,. Relief of idiopathic subjective tinnitus: is gabapentin effective? Arch Otolaryngol Head Neck Surg 2007; 133: 390-397. (Pubitemid 46631592)
17. Dobie RA, Sakai CS, Sullivan MD, Katon WJ, Russo J,. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit. Am J Otol 1993; 14: 18-23. (Pubitemid 23037487)
18. Pitovski DZ, Drescher MJ, Drescher DG,. Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites. Hear Res 1994; 77: 216-220. (Pubitemid 24201346)
19. ten Cate WJ, Curtis LM, Small GM, Rarey KE,. Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea. Laryngoscope 1993; 103: 865-871. (Pubitemid 23222261)
20. Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000; 122: 521-528. (Pubitemid 30210667)
21. Sakata E, Itoh A, Itoh Y,. Treatment of cochlear-tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 1996; 2: 129-135.
22. Cesarani A, Capobianco S, Soi D, Giuliano DA, Alpini D,. Intratympanic dexamethasone treatment for control of subjective idiopathic tinnitus: our clinical experience. Int Tinnitus J 2002; 8: 111-114. (Pubitemid 36008809)
23. Doyle KJ, Bauch C, Battista R, et al. Intratympanic steroid treatment: a review. Otol Neurotol 2004; 25: 1034-1039. (Pubitemid 39491693)
24. Akkuzu B, Yilmaz I, Cakmak O, Ozluoglu LN,. Efficacy of misoprostol in the treatment of tinnitus in patients with diabetes and/or hypertension. Auris Nasus Larynx 2004; 31: 226-232. (Pubitemid 39214988)
25. Yilmaz I, Akkuzu B, Cakmak O, Ozluoglu LN,. Misoprostol in the treatment of tinnitus: a double-blind study. Otolaryngol Head Neck Surg 2004; 130: 604-610. (Pubitemid 38656820)
26. Ahn JH, Kim TY, Kim YJ, Han MW, Yoon TH, Chung JW,. Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes. Diabet Med 2006; 23: 1339-1343. (Pubitemid 44787798)
27. Ahn JH, Kim MR, Kim HC,. Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss. Am J Otolaryngol 2005; 26: 245-248.
28. Suzuki H, Fujimura T, Shiomori T, et al. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2008; 35: 192-197. (Pubitemid 351474579)
29. Karliczek G, van den Dungen JJ, Brenken U, et al. Hemodynamic side effects of prostaglandin E1 in patients before and during cardiopulmonary bypass. Thorac Cardiovasc Surg 1981; 29: 55-59. (Pubitemid 11138487)